Macro: Sandcastle economics
Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.
Summary: The Japanese Yen experienced steep declines, with USDJPY reaching 145.83, nearing a test of 146. Notable movements occurred in crosses, with EURJPY testing 160, the highest since December. The Nasdaq 100 and S&P 500 approached record highs at 16,793 and 4,783, respectively. Meta surged 3.7% post a positive analyst report. The SEC approved spot bitcoin ETFs. Focus turns to the US CPI report today and the start of the US earnings season, featuring leading U.S. banks tomorrow.
Saxo’s Q1 2024 Outlook titled “What happened to the future” is now out. You can read it here.
The Saxo Quick Take is a short, distilled opinion on financial markets with references to key news and events.
US Equities: The Nasdaq 100 Index climbed 0.7% to 16,793, and the S&P 500 Index added 0.6% to 4,783, both just a touch shy of record highs. Meta rose 3.7% after a favorable analyst report. Nvidia gained 2.3%, and Microsoft was 1.9% higher. The SEC approved several spot bitcoin ETFs for the first time for trade starting Thursday. These approved ETFs include ARK 21Shares Bitcoin ETF, Bitwise Bitcoin ETF, Blackrock’s iShares Bitcoin Trust, Hashdex Bitcoin ETF, Fidelity Wise Origin Bitcoin Fund, Franklin Bitcoin ETF, Grayscale Bitcoin Trust GBTC, Invesco Galaxy Bitcoin ETF, Valkyrie Bitcoin Fund, VanEck Bitcoin Trust, and WisdomTree Bitcoin Fund. Eyes are now on the CPI report later today and the kickoff of the earnings season with leading U.S. banks reporting tomorrow.
Fixed income: Ahead of the CPI data on Thursday, Treasuries were steady. The 2-year yield ticked down 1bp to 4.36%, while the 10-year yield edged up 2bps to 4.03%. The money market is pricing in an approximately 70% chance of a 25bp rate cut at the March FOMC. Increasing discussion among traders about the timing of a slowdown or end to quantitative tightening has also increased. For more information, see this Saxo article.
China/HK Equities: The Hang Seng Index declined for the seventh consecutive day, falling 0.6% on Wednesday. The weakness was across the board, with notable underperformance in auto names. Pharmaceutical stocks bucked the market decline, seeing some gains. The CSI300 shed 0.5% while healthcare and solar outperformed. In anticipation of monetary easing, deflation, and sluggish economic growth, the Chinese 10-year government bond yield fell below 2.5% to close at 2.49%. At the CES consumer electronics show in Las Vegas, Xpeng announced that it will begin accepting orders for its flying cars later this year, with deliveries scheduled for late 2025.
FX: The dollar was mostly sideways ahead of the US CPI data scheduled for release today, however steep declines seen in the Japanese yen again. USDJPY rose to highs of 145.83, approaching a test of 146 which has held up last week and also for much of December. Bigger moves however seen on the crosses, with EURJPY testing 160, the highest levels since the start of December, and GBPJPY just shy of 186. EUR strength was also broad, and EURUSD surged above 1.0970 and 1.10 remains on watch. AUDUSD stuck around 0.67 despite the miss in Nov CPI yesterday, while kiwi slipped. Bitcoin was back in the spotlight following the SEC approval of ETFs, and XBTUSD now trades above 46,500 after an initial gain to over 47,500.
Commodities: Crude oil traded lower after the EIA reported a surprise 1.3m barrels stock build driven by a 2m b/d export slump, coming in contrast to API data that had shown inventory drawdown. Supply concerns also however accelerated with Houthi rebels escalating attacks. Gold struggled to keep its gains and reversed after touching $2,040, slipping back lower to sub-$2,030 levels.
Macro: Fed’s John Williams (voter) said that monetary policy is tight enough to nudge inflation down to the Fed’s 2% goal but policymakers need more evidence before they can “dial back” interest rates. He noted that risks to the economy are two sided, and rate decisions will be made meeting-by-meeting and driven by the totality of data. The NY Fed President sees 2024 GDP at around 1.25% (beneath Fed median Dec SEP of 1.4%), 2024 unemployment at 4% (beneath Fed median of 4.1%), 2024 inflation at 2.25% (beneath Fed median of 2.4%) and 2% in 2025 (beneath Fed median of 2.1%).
Macro events: US CPI (Dec) – preview here, US Jobless Claims, US Budget (Dec), Italy Industrial Production (Nov), Spain Industrial Production (Nov), Japan Regional Economic Report (Jan), Japan Economic Coincident Index (Nov).
Earnings: Infosys, Tesco, Marks & Spencer, Fast Retailing, Seven I, Largan Precision, Tata Consultancy
In the news:
For all macro, earnings, and dividend events check Saxo’s calendar.
For a global look at markets – go to Inspiration.
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)